Eli Lefler
Impact in
- Microbiology top 10%
- Ophthalmology top 5%
- Ocular Infections and Treatments
Papers in
-
- Infectious Diseases and Mycology 4
- Co-authors
- Uri RehanyShimon RumeltD. A. StevensDavid A. StevensD. MerzbachA. EitanA BickelEddy Barasch
- Journals
- Mycoses (3 papers)Cornea (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of the American Academy of Dermatology (1 paper)Mycopathologia (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Eli Lefler
21 papers receiving 310 citations
Peers
Comparison fields: 5 of 65
- Microbiology 10
- Ophthalmology 92
- Infectious Diseases 135
- Endocrinology 19
- Small Animals 25
Countries citing papers authored by Eli Lefler
This map shows the geographic impact of Eli Lefler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Lefler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lefler more than expected).
Fields of papers citing papers by Eli Lefler
This network shows the impact of papers produced by Eli Lefler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Lefler. The network helps show where Eli Lefler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eli Lefler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 1 | |
| 2 | 2004 | 16 | |
| 3 | 2004 | 67 | |
| 4 | 2001 | 27 | |
| 5 | 2001 | 9 | |
| 6 | 1998 | 42 | |
| 7 | 1998 | 11 | |
| 8 | 1994 | 6 | |
| 9 | 1992 | 10 | |
| 10 | 1992 | 6 | |
| 11 | Phaeohyphomycosis followed by paecilomycosis of nose septum in a neutropenic patient. | 1990 | 2 |
| 12 | 1989 | 17 | |
| 13 | Occurrence of Demodex in nose follicles of outpatients attending an otorhinolaryngology clinic. | 1989 | 3 |
| 14 | 1986 | 5 | |
| 15 | 1985 | 10 | |
| 16 | 1985 | 8 | |
| 17 | 1985 | 8 | |
| 18 | 1984 | 38 | |
| 19 | 1981 | 22 | |
| 20 | 1979 | 7 |
About Eli Lefler
Eli Lefler is a scholar working on Microbiology, Small Animals, Infectious Diseases, Ophthalmology and Virology, having authored 21 papers that have together received 329 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (7 papers), Ocular Infections and Treatments (4 papers), Infectious Diseases and Mycology (4 papers), Nail Diseases and Treatments (3 papers), Plant Pathogens and Fungal Diseases (3 papers), Rabies epidemiology and control (2 papers) and Phytoplasmas and Hemiptera pathogens (1 paper). The work is most often cited by research in Microbiology (10 citations), Ophthalmology (92 citations), Infectious Diseases (135 citations), Endocrinology (19 citations) and Small Animals (25 citations). Eli Lefler has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Uri Rehany, Shimon Rumelt, D. A. Stevens, David A. Stevens, D. Merzbach, A. Eitan, A Bickel, Eddy Barasch, Dietmar Urbach and Amnon Makler. Their work appears in journals such as Mycoses, Cornea, Antimicrobial Agents and Chemotherapy, Journal of the American Academy of Dermatology and Mycopathologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.